BioCina

About BioCina

BioCina is a global end-to-end Contract Development and Manufacturing Organization (CDMO) focused on accelerating therapies to market. Their mission is to provide high-value services with unrivaled quality and on-time delivery, while their vision is to be the most client-centric and reliable CDMO, enriching the lives of stakeholders.

Products & Services

Microbial:Bacterial protein expression platforms for microbial products, including whole cell vaccines.

Plasmid DNA (pDNA):Process development and bulk cGMP DNA adjuvants and plasmids for vaccines, cell and gene therapies, and mRNA production templates.

mRNA:Messenger RNA for preclinical research, toxicology studies, clinical trials, and commercial production of therapeutics and vaccines.

Lipid Nanoparticle (LNP):Encapsulation services supporting a wide range of applications.

Drug Product:Development, formulation, and analytical services for sterile liquids, clinical and commercial fill and finish manufacturing for small molecules and biologics.

Technology Transfer:Optimizing processes and accelerating product lifecycle with standardized tech transfer procedures.

Process Development:Designing and optimizing robust, scalable processes for microbial biologics, pDNA, mRNA, LNP, and sterile injectables.

Analytical Development:End-to-end analytical services including method transfer, development, and validation for various modalities.

cGMP Manufacturing:Flexible, phase-appropriate GMP manufacturing from preclinical to commercial across multiple modalities.

Quality and Regulatory:Ensuring compliance with global standards (TGA, FDA, EMA, Health Canada) and supporting inspection readiness.

Specialties

Microbial Biologics Plasmid DNA (pDNA) mRNA Therapeutics and Vaccines Lipid Nanoparticle (LNP) Encapsulation Sterile Injectables cGMP Manufacturing Process Development Analytical Development Technology Transfer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 3350000 MR: - FA: $5.0m AUD FAN: 3350000	D: 2023-04-26 FD: 2023-04-26	2 investors
2	RT: Grant T: - FT: Grant	A: 5000000 MR: - FA: $5.0m AUD FAN: 5000000	D: 2023-04-26 FD: 2023-04-26	2 investors
3	RT: Grant T: - FT: Grant	A: 5000000 MR: - FA: 5 million AUD FAN: 5000000	D: 2023-03-28 FD: 2023-03-28	2 investors

Grant Latest

2023-04-26

$3.4M

2 investors (Pro only)

Grant 2023-04-26

$5.0M

Grant 2023-03-28

$5.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Christina Yung

Human Resources Manager

M

Mark W. Womack

Chief Executive Officer

LinkedIn (Pro only)

D

Dan Young

Chief Financial Officer

LinkedIn (Pro only)

J

Jason Arcediano

Chief Commercial Officer

B

Brett Alderson

General Manager, Perth

M

Michael Tsaconas

Vice President, General Manager, Adelaide

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

BioCina Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised